Zura Bio Ltd - Class A

Research Zura Bio Ltd - Class A (ZURA) on Bullrun: market cap USD 534.18M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerZURA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 534.18M
• Financial periodFY2025
• Net income-USD 68.65M
• Free cash flow-USD 64.93M

Valuation Snapshot

latest market cap is USD 534.18M.

About Zura Bio Ltd - Class A

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development.

Frequently asked questions

What is Zura Bio Ltd - Class A's market cap?

Zura Bio Ltd - Class A's market capitalization is USD 534.18M.

What does Zura Bio Ltd - Class A do?

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States.